fashion -WSS

fashion

author：leisure time 2025-09-27 21:55:06 - browse：5537

Amedisys -- Hospital coverage from STAT — Option Care Health is buying Amedisys, creating a national company that specializes in almost all types of home care. Wikimedia Commons

Option Care Health is buying Amedisys in an all-stock merger valued at $3.6 billion, creating a national company that specializes in almost all types of home care that can be provided from cradle to grave.

Health insurance companies, providers, and patients have pushed for more care to be handled at home instead of a hospital or post-acute facility, under the idea that quality home care saves money and is what patients want. Option Care’s deal for Amedisys marks another instance of this push, and comes just a few months after UnitedHealth Group closed on its $5.4 billion acquisition of LHC Group.

But Wall Street was not receptive to the deal, driving down Option Care’s stock by more than 25% on Thursday morning.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Study suggests new cause of Down syndrome: cells linked to aging

knowledge

WSS

Merck to acquire Harpoon Therapeutics for $680 million

Merck to acquire Harpoon Therapeutics for $680 million

Editas, Vertex strike deal on CRISPR

Christmas in the PICU brings some surprising joy

CRISPR gene editing developments we’re watching in 2024

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

explore

fashion

entertainment

23andMe had bad news about my health. I wish a person had delivered it

What STAT readers think about the FDA and patient advocacy

Apple is now the first public company to be valued at $3 trillion

In shift, Texas to cover initial consult for Afghan baby's gene therapy

Virginia high school admissions case could be legal follow

Christmas in the PICU brings some surprising joy

At least 13 dead in Texas as scorching temps continue

How to keep neuroscience’s past racism from being its future

Anesthesiologist group: stop taking Ozempic before surgery

Gene therapy denied for Afghan refugee whose father aided U.S.

entertainment

What STAT readers think about the FDA and patient advocacy

Hospitals owned by private equity see complications spike 25%

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Prime Medicine, Myeloid Therapeutics clash over genome

Why health records don't always know when patients are dead

In Spain, a hospital brews its own CAR

focus

explore

knowledge

hotspot